Landsberg Bennett & Dubbaneh’s Teladoc Health TDOC Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,713	Closed	-$1.77M	–	275
2021 Q1	$1.77M	Sell	9,713 -4,141	-30%	-$960K	0.25%	96
2020 Q4	$2.77M	Buy	13,854 +664	+5%	+$135K	0.42%	72
2020 Q3	$2.87M	Sell	13,190 -6,625	-33%	-$1.4M	0.5%	59
2020 Q2	$3.71M	Sell	19,815 -7,893	-28%	-$1.38M	0.77%	38
2020 Q1	$4.41M	Sell	27,708 -4,779	-15%	-$556K	1.23%	23
2019 Q4	$2.71M	Sell	32,487 -3,787	-10%	-$288K	0.64%	50
2019 Q3	$2.41M	Sell	36,274 -234	-0.6%	-$15.4K	0.65%	59
2019 Q2	$2.47M	Sell	36,508 -3,049	-8%	-$178K	0.65%	55
2019 Q1	$2.19M	Buy	+39,557	New	+$2.42M	0.52%	71

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's TDOC Position: Q2 2021 in Review

Landsberg Bennett & Dubbaneh sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 9,713 shares — an estimated $1.77M sold.

Landsberg Bennett & Dubbaneh first reported a position in TDOC in Q1 2019 and held it in 9 quarters. The position peaked at $4.41M in Q1 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

Landsberg Bennett & Dubbaneh reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
Landsberg Bennett & Dubbaneh sold 9,713 Teladoc Health shares in Q2 2021, an estimated $1.77M.
Landsberg Bennett & Dubbaneh first reported a position in Teladoc Health in Q1 2019 and held it in 9 quarters.
Landsberg Bennett & Dubbaneh's Teladoc Health position peaked at $4.41M in Q1 2020.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q2 2021, filed 29 Jul 2021.